Brokerages Set ArriVent BioPharma, Inc. (NASDAQ:AVBP) PT at $44.83
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have issued a buy […]
5 Aug 05:44 · The Markets Daily